<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"><channel rdf:about="http://onlinelibrary.wiley.com/rss/journal/10.1111/(ISSN)1610-0387" xmlns="http://purl.org/rss/1.0/"><title>JDDG: Journal der Deutschen Dermatologischen Gesellschaft</title><description> Wiley Online Library : JDDG: Journal der Deutschen Dermatologischen Gesellschaft</description><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2F%28ISSN%291610-0387</link><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc</dc:publisher><dc:language xmlns:dc="http://purl.org/dc/elements/1.1/">en</dc:language><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/">© Blackwell Verlag GmbH, Berlin</dc:rights><prism:issn xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">1610-0379</prism:issn><prism:eIssn xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">1610-0387</prism:eIssn><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-06-01T00:00:00-05:00</dc:date><prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">June 2013</prism:coverDisplayDate><prism:volume xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">11</prism:volume><prism:number xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">s3</prism:number><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">1</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">45</prism:endingPage><image rdf:resource="http://onlinelibrary.wiley.com/store/10.1111/ddg.2013.11.issue-s3/asset/cover.gif?v=1&amp;s=65df925ea061f696818f13dc333cd8b3d61aefca"/><items><rdf:Seq><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12110"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12094"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12118"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12116"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12099"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12119"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12042"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12101"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12111"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12109"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12049"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12089"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12056"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12096"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12095"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12091"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12075"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12043"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12073"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12067"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12088"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12057"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12038"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fj.1610-0387.2012.08071.x"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fj.1610-0387.2012.08049.x"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12072"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12037"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12028"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12009"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fj.1610-0387.2012.08078.x"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fj.1610-0387.2012.12506.x"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fj.1610-0387.2011.07880.x"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fj.1610-0387.2011.07813.x"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fj.1610-0379.2012.8018_1.x"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fj.1610-0379.2012.8018.x"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12015_1"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12015"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fj.1610-0379.2012.8018_2.x"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12015_2"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fj.1610-0379.2012.8018_3.x"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12015_3"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fj.1610-0379.2012.8018_4.x"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12015_4"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fj.1610-0379.2012.8018_5.x"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12015_5"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fj.1610-0379.2012.8018_6.x"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12015_6"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fj.1610-0379.2012.8018_7.x"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12015_7"/></rdf:Seq></items></channel><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12110" xmlns="http://purl.org/rss/1.0/"><title>Pulsed dye laser (FPDL) treatment of a plantar verruca vulgaris and in vivo monitoring of therapy with confocal laser scan microscopy (CLSM)</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12110</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Pulsed dye laser (FPDL) treatment of a plantar verruca vulgaris and in vivo monitoring of therapy with confocal laser scan microscopy (CLSM)</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Sezgin Erdoğan, Peter Dorittke, Bernd Kardorff</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-16T07:10:23.459583-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/ddg.12110</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/ddg.12110</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12110</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Correspondence</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12094" xmlns="http://purl.org/rss/1.0/"><title>Bullous pemphigoid appearing both on thermal burn scars and split-thickness skin graft donor sites</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12094</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Bullous pemphigoid appearing both on thermal burn scars and split-thickness skin graft donor sites</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Iria Neri, Valentina A. Antonucci, Riccardo Balestri, Vera Tengattini, Ivano Iozzo, Federico Bardazzi</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-16T07:10:20.983488-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/ddg.12094</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/ddg.12094</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12094</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Correspondence</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12118" xmlns="http://purl.org/rss/1.0/"><title>UV-induced occupational skin cancer: possibilities of secondary individual prevention in the “Dermatologist's Procedure”</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12118</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">UV-induced occupational skin cancer: possibilities of secondary individual prevention in the “Dermatologist's Procedure”</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Peter Elsner, Otto Blome, Thomas Ludwig Diepgen</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-13T07:44:35.615698-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/ddg.12118</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/ddg.12118</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12118</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Review</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Summary</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Invasive squamous cell carcinoma (SCC) as a “quasi occupational disease” according to §9 Section 2 of the German Social Code Book (SGB) VII typically develops on chronically UV-damaged skin from actinic keratoses. After the Medical Scientific Committee of the Federal Ministry of Labor and Social Affairs has confirmed the legal criteria for acknowledging UV-induced SCC as an occupational disease, it is expected that the condition will be added to the official list of occupational diseases issued by the Federal Government in the near future. The Social Accident Insurance is required by law (§3 Occupational Disease Regulation) to prevent these tumors by <b>“</b>all appropriate means“. There are excellent therapeutic and preventive measures for the management of actinic keratoses to avoid the development of SCC. The <b>“</b>Dermatologist's Procedure“according to §§ 41–43 of the agreement between the Social Accident Insurance and the Federal Medical Association was established in Germany in 1972 to take preventive measures in insured persons with skin lesions possibly developing into an occupational disease, or worsening it, or leading to a recurrence of it This procedure proved to be very successful in the prevention of severe and/or recurring skin diseases forcing a worker to leave his job. On the basis of this agreement, the Social Accident Insurance has the instruments to independently provide preventive measures for the new occupational skin disease SCC induced by natural UV light according to §9 Section 2 of the German Social Code Book (SGB) VII.</p></div>
]]></content:encoded><description>

Invasive squamous cell carcinoma (SCC) as a “quasi occupational disease” according to §9 Section 2 of the German Social Code Book (SGB) VII typically develops on chronically UV-damaged skin from actinic keratoses. After the Medical Scientific Committee of the Federal Ministry of Labor and Social Affairs has confirmed the legal criteria for acknowledging UV-induced SCC as an occupational disease, it is expected that the condition will be added to the official list of occupational diseases issued by the Federal Government in the near future. The Social Accident Insurance is required by law (§3 Occupational Disease Regulation) to prevent these tumors by “all appropriate means“. There are excellent therapeutic and preventive measures for the management of actinic keratoses to avoid the development of SCC. The “Dermatologist's Procedure“according to §§ 41–43 of the agreement between the Social Accident Insurance and the Federal Medical Association was established in Germany in 1972 to take preventive measures in insured persons with skin lesions possibly developing into an occupational disease, or worsening it, or leading to a recurrence of it This procedure proved to be very successful in the prevention of severe and/or recurring skin diseases forcing a worker to leave his job. On the basis of this agreement, the Social Accident Insurance has the instruments to independently provide preventive measures for the new occupational skin disease SCC induced by natural UV light according to §9 Section 2 of the German Social Code Book (SGB) VII.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12116" xmlns="http://purl.org/rss/1.0/"><title>Slow growth of hair and nails, craniofacial abnormalities and brachyphalangy</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12116</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Slow growth of hair and nails, craniofacial abnormalities and brachyphalangy</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Robert Gruber, Anna Sarah Schossig, Kholood A. Alnutaifi, Verena Martinz, Stefan Blunder, Johannes Zschocke, Matthias Schmuth, Sigrid Tinschert</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-13T07:42:36.511678-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/ddg.12116</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/ddg.12116</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12116</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Case for Diagnosis</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12099" xmlns="http://purl.org/rss/1.0/"><title>Cutaneous clear cell sarcoma in a 12-year-old boy</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12099</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Cutaneous clear cell sarcoma in a 12-year-old boy</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Katharina Schwede, Tino Wetzig, Jan C. Simon, Lars Fischer, Claudia Wickenhauser, Leo Schärer, Mirjana Ziemer</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-13T07:42:31.589334-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/ddg.12099</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/ddg.12099</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12099</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Letters</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12119" xmlns="http://purl.org/rss/1.0/"><title>Photodynamic therapy for skin rejuvenation: treatment options – results of a consensus conference of an expert group for aesthetic photodynamic therapy</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12119</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Photodynamic therapy for skin rejuvenation: treatment options – results of a consensus conference of an expert group for aesthetic photodynamic therapy</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Rolf-Markus Szeimies, Stephan Lischner, Wolfgang Philipp-Dormston, Thorsten Walker, Dagmar Hiepe-Wegener, Konstantin Feise, Maurizio Podda, Welf Prager, Elisabeth Kohl, Sigrid Karrer</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-08T03:24:02.912442-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/ddg.12119</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/ddg.12119</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12119</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Review</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Summary</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>In addition to providing effective treatment for non-melanoma skin cancers or their precursors, photodynamic therapy (PDT) has also attracted considerable attention for its use on aesthetic dermatology. In a first consensus publication the mechanisms of action of its photorejuvenation effects and recent studies were presented; in this paper treatment protocols for the different anatomical regions exposed to chronic sun damage like face, neck, décolleté and the back of the hands are given and suitable procedures for pre- and after-care are discussed.</p></div>]]></content:encoded><description>

In addition to providing effective treatment for non-melanoma skin cancers or their precursors, photodynamic therapy (PDT) has also attracted considerable attention for its use on aesthetic dermatology. In a first consensus publication the mechanisms of action of its photorejuvenation effects and recent studies were presented; in this paper treatment protocols for the different anatomical regions exposed to chronic sun damage like face, neck, décolleté and the back of the hands are given and suitable procedures for pre- and after-care are discussed.</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12042" xmlns="http://purl.org/rss/1.0/"><title>Drug-induced hperpigemntation: a systematic review</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12042</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Drug-induced hperpigemntation: a systematic review</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Walter Krause</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-08T03:23:49.812625-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/ddg.12042</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/ddg.12042</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12042</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Original Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Summary</h3>
<div class="section" id="ddg12042-sec-0010" xmlns="http://www.w3.org/1999/xhtml"><h4>Background</h4><div class="para"><p>Acquired hyperpigmentation of the skin is sometimes interpreted as an adverse effect of drugs. Systematic studies are rare in the literature; predominantly case reports have been published. The present review provides evaluates the evidence for a causal relation.</p></div></div>
<div class="section" id="ddg12042-sec-0020" xmlns="http://www.w3.org/1999/xhtml"><h4>Methods</h4><div class="para"><p>The reports on a relationship between hyperpigmentation and drugs from 1970 until June 2012 found in MEDLINE and EMBASE were rated according to the SIGN grading system for clinical studies. In this system, the grade of evidence of each report is rated. The highest grade of evidence for each drug is cited.</p></div></div>
<div class="section" id="ddg12042-sec-0030" xmlns="http://www.w3.org/1999/xhtml"><h4>Results</h4><div class="para"><p>306 publications were included. They were predominantly case reports; only a small number of case series was available. Only very few case-control-studies and randomized controlled trials (RCT) were found. For the majority of drugs, there was a low level of evidence for a causal relationship in drug-induced hyperpigmentation. A causal relationship is likely only for prostaglandins, minocycline, phenothiazine, nicotine, and antimalarial drugs.</p></div></div>
<div class="section" id="ddg12042-sec-0040" xmlns="http://www.w3.org/1999/xhtml"><h4>Conclusions</h4><div class="para"><p>There is little evidence for drug-induced hyperpigmentation. A causal relationship appears liklely only for a limited number of drugs.</p></div></div>
]]></content:encoded><description>


Background
Acquired hyperpigmentation of the skin is sometimes interpreted as an adverse effect of drugs. Systematic studies are rare in the literature; predominantly case reports have been published. The present review provides evaluates the evidence for a causal relation.


Methods
The reports on a relationship between hyperpigmentation and drugs from 1970 until June 2012 found in MEDLINE and EMBASE were rated according to the SIGN grading system for clinical studies. In this system, the grade of evidence of each report is rated. The highest grade of evidence for each drug is cited.


Results
306 publications were included. They were predominantly case reports; only a small number of case series was available. Only very few case-control-studies and randomized controlled trials (RCT) were found. For the majority of drugs, there was a low level of evidence for a causal relationship in drug-induced hyperpigmentation. A causal relationship is likely only for prostaglandins, minocycline, phenothiazine, nicotine, and antimalarial drugs.


Conclusions
There is little evidence for drug-induced hyperpigmentation. A causal relationship appears liklely only for a limited number of drugs.

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12101" xmlns="http://purl.org/rss/1.0/"><title>Rosacea – S1 Guideline</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12101</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Rosacea – S1 Guideline</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Markus Reinholz, Julia K. Tietze, Katharina Kilian, Martin Schaller, Helmut Schöfer, Percy Lehmann, Manfred Zierhut, Winfried Klövekorn, Thomas Ruzicka, Jürgen Schauber</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-06T05:03:40.745796-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/ddg.12101</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/ddg.12101</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12101</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Guideline</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12111" xmlns="http://purl.org/rss/1.0/"><title>Current resistance patterns of Staphylococcus aureus towards topical antibiotics and relevant antiseptics in patients with atopic dermatitis and impetigo</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12111</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Current resistance patterns of Staphylococcus aureus towards topical antibiotics and relevant antiseptics in patients with atopic dermatitis and impetigo</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Dolores Thum, Hans-Peter Seidl, Rüdiger Hein, Johannes Ring, Christian Andres, Martin Mempel</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-29T03:26:22.204183-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/ddg.12111</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/ddg.12111</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12111</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Scientific Letter</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12109" xmlns="http://purl.org/rss/1.0/"><title>Multiple eruptive keratoacanthomas: a confusing term?</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12109</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Multiple eruptive keratoacanthomas: a confusing term?</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Ahmad Nofal, Eman Nofal</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-29T03:25:22.591852-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/ddg.12109</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/ddg.12109</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12109</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Letter</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12049" xmlns="http://purl.org/rss/1.0/"><title>Papulopustular eruption after holiday in a 44-year-old man</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12049</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Papulopustular eruption after holiday in a 44-year-old man</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Birka Brauns, Michael P. Schön, Martin Mempel</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-29T03:25:21.243162-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/ddg.12049</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/ddg.12049</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12049</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Case for Diagnosis</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12089" xmlns="http://purl.org/rss/1.0/"><title>Prevalence and treatment profile of patients with grass pollen and house dust mite allergy</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12089</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Prevalence and treatment profile of patients with grass pollen and house dust mite allergy</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Margitta Worm, Hae-Hyuk Lee, Karel Kostev</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-18T09:54:18.064222-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/ddg.12089</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/ddg.12089</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12089</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Original Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Summary</h3>
<div class="section" id="ddg12089-sec-0010" xmlns="http://www.w3.org/1999/xhtml"><h4>Background</h4><div class="para"><p>In Europe, grass pollen and house dust mites are the most common allergens responsible for IgE-mediated allergies. The aim of our study was to examine the data provided by various medical practices specialized in allergic diseases in Germany regarding patients with rhinoconjunctivitis in terms of demographic data and the prescribed treatment by different medical specialists.</p></div></div>
<div class="section" id="ddg12089-sec-0020" xmlns="http://www.w3.org/1999/xhtml"><h4>Patients and methods</h4><div class="para"><p>Data from patients who were diagnosed with allergic rhinoconjunctivitis were taken from the “disease-analyzer” database (IMS Health GmbH) and analyzed. The data assessment was anonymous in accordance with the guidelines for data protection. The information collected included specific data about diagnosis and treatment in private practices in Germany.</p></div></div>
<div class="section" id="ddg12089-sec-0030" xmlns="http://www.w3.org/1999/xhtml"><h4>Results</h4><div class="para"><p>The majority of patients with grass pollen allergy were treated by their general practitioners, while those with house dust mite allergy were treated by a specialist with a background in allergic diseases (pulmonologists, otorhinolaryngologists, and dermatologists). Treatment was primarily symptomatic, usually consisting of antihistamines. Allergen-specific immunotherapy, the only causal treatment for IgE-mediated allergies at present, was performed rarely.</p></div></div>
<div class="section" id="ddg12089-sec-0040" xmlns="http://www.w3.org/1999/xhtml"><h4>Conclusions</h4><div class="para"><p>The data suggest the need for interaction and knowledge transfer between various specialists in order to improve patient-centered care in regard to allergic diseases.</p></div></div>
]]></content:encoded><description>


Background
In Europe, grass pollen and house dust mites are the most common allergens responsible for IgE-mediated allergies. The aim of our study was to examine the data provided by various medical practices specialized in allergic diseases in Germany regarding patients with rhinoconjunctivitis in terms of demographic data and the prescribed treatment by different medical specialists.


Patients and methods
Data from patients who were diagnosed with allergic rhinoconjunctivitis were taken from the “disease-analyzer” database (IMS Health GmbH) and analyzed. The data assessment was anonymous in accordance with the guidelines for data protection. The information collected included specific data about diagnosis and treatment in private practices in Germany.


Results
The majority of patients with grass pollen allergy were treated by their general practitioners, while those with house dust mite allergy were treated by a specialist with a background in allergic diseases (pulmonologists, otorhinolaryngologists, and dermatologists). Treatment was primarily symptomatic, usually consisting of antihistamines. Allergen-specific immunotherapy, the only causal treatment for IgE-mediated allergies at present, was performed rarely.


Conclusions
The data suggest the need for interaction and knowledge transfer between various specialists in order to improve patient-centered care in regard to allergic diseases.

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12056" xmlns="http://purl.org/rss/1.0/"><title>Syncancerogenesis in occupational dermatology</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12056</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Syncancerogenesis in occupational dermatology</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Heinrich Dickel, Peter Altmeyer</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-11T03:59:48.919277-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/ddg.12056</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/ddg.12056</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12056</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Letters</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12096" xmlns="http://purl.org/rss/1.0/"><title>Factor-XI-deficiency: perioperative coagulation management in a patient with an extensive squamous cell carcinoma of the shin</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12096</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Factor-XI-deficiency: perioperative coagulation management in a patient with an extensive squamous cell carcinoma of the shin</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Léa Trémezaygues, Jörg-Lennart Borchers, Roushanak Shayesteh-Kheslat, Thomas Vogt, Knuth Rass</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-10T01:44:32.645548-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/ddg.12096</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/ddg.12096</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12096</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Dermatosurgery – Tricks of the Trade</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12095" xmlns="http://purl.org/rss/1.0/"><title>Treatment of tinea capitis – griseofulvin versus fluconazole – a comparative study</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12095</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Treatment of tinea capitis – griseofulvin versus fluconazole – a comparative study</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Avner Shemer, Ira Bernstein Plotnik, Batya Davidovici, Marcelo H. Grunwald, Ronen Magun, Boaz Amichai</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-10T01:44:32.236903-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/ddg.12095</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/ddg.12095</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12095</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Original Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Summary</h3>
<div class="section" id="ddg12095-sec-0010" xmlns="http://www.w3.org/1999/xhtml"><h4>Objective</h4><div class="para"><p>To compare the efficacy and safety of fluconazole and griseofulvin in the treatment of tinea capitis.</p></div></div>
<div class="section" id="ddg12095-sec-0020" xmlns="http://www.w3.org/1999/xhtml"><h4>Patients and Methods</h4><div class="para"><p>Patients with tinea capitis (n = 113) with positive fungal cultures entered the study. The patients were divided into four groups with different treatment regimes. Two groups received griseofulvin 15 or 25 mg/kg/day and two groups received fluconazole 4 or 6 mg/kg/day, all for up to 12 weeks.</p></div></div>
<div class="section" id="ddg12095-sec-0030" xmlns="http://www.w3.org/1999/xhtml"><h4>Results</h4><div class="para"><p>Griseofulvin was found to be slightly better than fluconazole. The lower doses for both griseofulvin and fluconazole required significantly longer treatment duration until mycological cure than the higher doses, independent of the fungus type.</p></div></div>
<div class="section" id="ddg12095-sec-0040" xmlns="http://www.w3.org/1999/xhtml"><h4>Conclusions</h4><div class="para"><p>Since no significant difference was found between the drugs, it is suggested that the choice should be based on tolerability, availability and cost of the drugs.</p></div></div>
]]></content:encoded><description>


Objective
To compare the efficacy and safety of fluconazole and griseofulvin in the treatment of tinea capitis.


Patients and Methods
Patients with tinea capitis (n = 113) with positive fungal cultures entered the study. The patients were divided into four groups with different treatment regimes. Two groups received griseofulvin 15 or 25 mg/kg/day and two groups received fluconazole 4 or 6 mg/kg/day, all for up to 12 weeks.


Results
Griseofulvin was found to be slightly better than fluconazole. The lower doses for both griseofulvin and fluconazole required significantly longer treatment duration until mycological cure than the higher doses, independent of the fungus type.


Conclusions
Since no significant difference was found between the drugs, it is suggested that the choice should be based on tolerability, availability and cost of the drugs.

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12091" xmlns="http://purl.org/rss/1.0/"><title>Urticaria and angioedema after consumption of red meat</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12091</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Urticaria and angioedema after consumption of red meat</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Giada Heber, Susanne Abraham, Andrea Bauer</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-10T01:44:23.578744-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/ddg.12091</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/ddg.12091</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12091</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Letters</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12075" xmlns="http://purl.org/rss/1.0/"><title>Complete remission of severe chronic recurrent angioedema of unknown cause with omalizumab</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12075</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Complete remission of severe chronic recurrent angioedema of unknown cause with omalizumab</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Antonie Websky, Kristian Reich, Volker Steinkraus, Kristine Breuer</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-10T01:44:21.02774-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/ddg.12075</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/ddg.12075</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12075</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Letters</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12043" xmlns="http://purl.org/rss/1.0/"><title>Firm nodule in the perianal region of a 59-year-old woman</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12043</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Firm nodule in the perianal region of a 59-year-old woman</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Maria Zywica, Wolfgang Hartschuh, Corinna Hamsch</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-10T01:44:19.84731-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/ddg.12043</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/ddg.12043</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12043</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Case for Diagnosis</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12073" xmlns="http://purl.org/rss/1.0/"><title>Optical coherence tomography: its role in daily dermatological practice</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12073</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Optical coherence tomography: its role in daily dermatological practice</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Lutz Schmitz, Uwe Reinhold, Erhard Bierhoff, Thomas Dirschka</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-09T04:34:44.124958-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/ddg.12073</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/ddg.12073</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12073</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Review Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Summary</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Optical coherence tomography (OCT) is a non-invasive, tomographic imaging technique which generates high-resolution in-vivo images up to mid-dermal layers. Due to continuous technological improvements, OCT is moving from research projects into daily dermatological practice. It can complement other imaging methods like high-frequency ultrasound or confocal microscopy. There is a wide variety of indications for OCT. In addition to aiding in the diagnosis and clinical monitoring of inflammatory dermatoses, OCT is a very useful and feasible technique in dermato-oncology.</p></div>
]]></content:encoded><description>

Optical coherence tomography (OCT) is a non-invasive, tomographic imaging technique which generates high-resolution in-vivo images up to mid-dermal layers. Due to continuous technological improvements, OCT is moving from research projects into daily dermatological practice. It can complement other imaging methods like high-frequency ultrasound or confocal microscopy. There is a wide variety of indications for OCT. In addition to aiding in the diagnosis and clinical monitoring of inflammatory dermatoses, OCT is a very useful and feasible technique in dermato-oncology.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12067" xmlns="http://purl.org/rss/1.0/"><title>Depression is a frequent co-morbidity in patients with acne inversa</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12067</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Depression is a frequent co-morbidity in patients with acne inversa</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Agata Kurek, Eva Milena Johanne Peters, Robert Sabat, Wolfram Sterry, Sylke Schneider-Burrus</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-09T04:34:11.550288-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/ddg.12067</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/ddg.12067</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12067</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Original Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Summary</h3>
<div class="section" id="ddg12067-sec-0010" xmlns="http://www.w3.org/1999/xhtml"><h4>Background</h4><div class="para"><p>Acne inversa (AI) is a common chronic inflammatory disease that has a profound impact on the patientsí quality of life. We hypothesized a higher level of depression in AI patients compared to controls.</p></div></div>
<div class="section" id="ddg12067-sec-0020" xmlns="http://www.w3.org/1999/xhtml"><h4>Objectives</h4><div class="para"><p>We studied depression in patients with AI and control subjects. Additionally, we evaluated whether the severity of the disease, anxiety, sexual distress and acute inflammation may have an influence on depression.</p></div></div>
<div class="section" id="ddg12067-sec-0030" xmlns="http://www.w3.org/1999/xhtml"><h4>Patients and Methods</h4><div class="para"><p>The Hospital Anxiety and Depression Scale (HADS) was given to 90 voluntary study participants to assess depression in AI patients and in age-, gender-, and BMI-matched controls. Moreover, the correlation between depression and conjectural influencing factors was evaluated.</p></div></div>
<div class="section" id="ddg12067-sec-0040" xmlns="http://www.w3.org/1999/xhtml"><h4>Results</h4><div class="para"><p>This study demonstrated that AI patients have a higher depression score than matched controls. Importantly, 38.6 % of AI patients are affected by depression compared to 2.4 % of the control subjects. In contrast to the duration of the disease and the AI patientsí age, anxiety and sexual distress showed a strong correlation with the degree of depression.</p></div></div>
<div class="section" id="ddg12067-sec-0050" xmlns="http://www.w3.org/1999/xhtml"><h4>Conclusions</h4><div class="para"><p>Patients with AI have a higher risk of developing depression. Physicians should be alert to the possible development of depression when treating patients with this disorder.</p></div></div>
]]></content:encoded><description>


Background
Acne inversa (AI) is a common chronic inflammatory disease that has a profound impact on the patientsí quality of life. We hypothesized a higher level of depression in AI patients compared to controls.


Objectives
We studied depression in patients with AI and control subjects. Additionally, we evaluated whether the severity of the disease, anxiety, sexual distress and acute inflammation may have an influence on depression.


Patients and Methods
The Hospital Anxiety and Depression Scale (HADS) was given to 90 voluntary study participants to assess depression in AI patients and in age-, gender-, and BMI-matched controls. Moreover, the correlation between depression and conjectural influencing factors was evaluated.


Results
This study demonstrated that AI patients have a higher depression score than matched controls. Importantly, 38.6 % of AI patients are affected by depression compared to 2.4 % of the control subjects. In contrast to the duration of the disease and the AI patientsí age, anxiety and sexual distress showed a strong correlation with the degree of depression.


Conclusions
Patients with AI have a higher risk of developing depression. Physicians should be alert to the possible development of depression when treating patients with this disorder.

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12088" xmlns="http://purl.org/rss/1.0/"><title>Primary wound closure with tension – tips and tricks</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12088</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Primary wound closure with tension – tips and tricks</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Franziska Carola Eberle, Markus Krug, Helmut Breuninger, Hans-Martin Häfner</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-02T04:46:28.129771-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/ddg.12088</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/ddg.12088</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12088</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Dermatosurgery – Tricks of the Trade</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12057" xmlns="http://purl.org/rss/1.0/"><title>Anti-laminin γ1 pemphigoid</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12057</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Anti-laminin γ1 pemphigoid</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Eva Corina Kalkoff, Isa Bramsiepe, Stephanie Groth, Wolfgang Christian Marsch, Burkhard Kreft</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-10T10:41:26.468737-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/ddg.12057</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/ddg.12057</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12057</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Letters</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12038" xmlns="http://purl.org/rss/1.0/"><title>Improved patient-centered care with effective use of Integra® in dermatologic reconstructive surgery</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12038</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Improved patient-centered care with effective use of Integra® in dermatologic reconstructive surgery</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Cornelia Sigrid Lissi Müller, Claudia Schiekofer, Rebecca Körner, Claudia Pföhler, Thomas Vogt</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-06T09:40:50.752855-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/ddg.12038</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/ddg.12038</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12038</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Original Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Summary</h3>
<div class="section" id="ddg12038-sec-0010" xmlns="http://www.w3.org/1999/xhtml"><h4>Background</h4><div class="para"><p>The incidence of skin tumors is increasing among elderly patients, and the multi-morbidities which occur in the elderly are a great challenge for dermatologic surgeons. The currently required safety margins for different types of melanomas and non-melanoma skin cancers lead to extensive and profound wounds.</p></div></div>
<div class="section" id="ddg12038-sec-0020" xmlns="http://www.w3.org/1999/xhtml"><h4>Objective</h4><div class="para"><p>To investigate the usefulness of a dermal substitute (Integra®) for routine use in surgery for dermatologic tumors.</p></div></div>
<div class="section" id="ddg12038-sec-0030" xmlns="http://www.w3.org/1999/xhtml"><h4>Patients and Methods</h4><div class="para"><p>In this retrospective study 20 patients underwent sequential surgeries for skin cancer. Wound closures were performed using Integra® (single layer) and immediate split-thickness skin graft.</p></div></div>
<div class="section" id="ddg12038-sec-0040" xmlns="http://www.w3.org/1999/xhtml"><h4>Results</h4><div class="para"><p>Twenty-two tumors (6 malignant melanomas, 10 squamous cell carcinomas, 2 pleomorphic sarcomas, 1 basal cell carcinoma, 2 Merkel cell carcinomas, and 1 trichoblastic carcinoma) were resected. The mean defect size was 41.4 cm<sup>2</sup>. All transplants were (65–100 %) vital; however, defects in the midface (cheek and infra-orbital area) often healed with esthetically disturbing, dense, pillow-like scars.</p></div></div>
<div class="section" id="ddg12038-sec-0050" xmlns="http://www.w3.org/1999/xhtml"><h4>Conclusions</h4><div class="para"><p>With the use of Integra®, the duration of hospitalization was decreased, patients with multi-morbidities were effectively treated, and functionally- and esthetically-satisfactory outcomes were achieved. On the basis of these observations, we discuss points of handling those patients who require rapid and effective surgery and undergo dermatologic surgery using dermal substitutes.</p></div></div>
]]></content:encoded><description>


Background
The incidence of skin tumors is increasing among elderly patients, and the multi-morbidities which occur in the elderly are a great challenge for dermatologic surgeons. The currently required safety margins for different types of melanomas and non-melanoma skin cancers lead to extensive and profound wounds.


Objective
To investigate the usefulness of a dermal substitute (Integra®) for routine use in surgery for dermatologic tumors.


Patients and Methods
In this retrospective study 20 patients underwent sequential surgeries for skin cancer. Wound closures were performed using Integra® (single layer) and immediate split-thickness skin graft.


Results
Twenty-two tumors (6 malignant melanomas, 10 squamous cell carcinomas, 2 pleomorphic sarcomas, 1 basal cell carcinoma, 2 Merkel cell carcinomas, and 1 trichoblastic carcinoma) were resected. The mean defect size was 41.4 cm2. All transplants were (65–100 %) vital; however, defects in the midface (cheek and infra-orbital area) often healed with esthetically disturbing, dense, pillow-like scars.


Conclusions
With the use of Integra®, the duration of hospitalization was decreased, patients with multi-morbidities were effectively treated, and functionally- and esthetically-satisfactory outcomes were achieved. On the basis of these observations, we discuss points of handling those patients who require rapid and effective surgery and undergo dermatologic surgery using dermal substitutes.

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fj.1610-0387.2012.08071.x" xmlns="http://purl.org/rss/1.0/"><title>Drug supply for psoriasis – results from a national pharmacy network</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fj.1610-0387.2012.08071.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Drug supply for psoriasis – results from a national pharmacy network</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Nadine Franzke, Moritz Montenbruck, Anna Katharina Langenbruch, Florian C. Beikert, Joachim Kresken, Matthias Augustin</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-06T06:55:25.483353-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1610-0387.2012.08071.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1610-0387.2012.08071.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fj.1610-0387.2012.08071.x</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Original Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Summary</h3>
<div class="section" id="ddg8071-sec-0010" xmlns="http://www.w3.org/1999/xhtml"><h4>Background</h4><div class="para"><p>In Germany, drugs are to a large extent provided by pharmacies. Thus, investigations in pharmacies permit drug usage studies both on patients receiving prescribable drugs and using self-medication. The current study evaluated the quality of medical care, disease burden and spectrum of treatments for patients with psoriasis in a nationwide network of pharmacies.</p></div></div>
<div class="section" id="ddg8071-sec-0020" xmlns="http://www.w3.org/1999/xhtml"><h4>Patients and methods</h4><div class="para"><p>A nationwide cross-sectional study was conducted in 61 pharmacies. Patients with psoriasis vulgaris who came to the pharmacy to obtain antipsoriatic drugs or basic ointments were consecutively recruited, interviewed and asked to complete a standardized questionnaire. The questionnaire focused on socio-demographic characteristics and prior therapies for psoriasis. Furthermore, data on the patient's treatment satisfaction, disease-related burden, and treatment adherence were evaluated. In addition, the proportion and significance of health care providers for psoriasis as well as the number of patients using self-medication were assessed.</p></div></div>
<div class="section" id="ddg8071-sec-0030" xmlns="http://www.w3.org/1999/xhtml"><h4>Results</h4><div class="para"><p>The data on 241 patients show a high and long-lasting disease-related burden. A high utilization of resources was found. Dermatologists were the most frequently consulted providers (reported by 77.1 % of patients), followed by general practitioners (10.4 %). 3.5 % of patients were using self-medication. Self-reported adherence with treatment was moderate (71.6 %). Patient satisfaction varied considerably and demonstrated the need for improvement.</p></div></div>
<div class="section" id="ddg8071-sec-0040" xmlns="http://www.w3.org/1999/xhtml"><h4>Conclusions</h4><div class="para"><p>Psoriasis is a socio-economically relevant disease. Health care is provided primarily by dermatologists. Surveying patients in a national network of pharmacies is a unique and effective way of collecting relevant “real world” data. Selection biases related to the health care setting are minimized.</p></div></div>
]]></content:encoded><description>


Background
In Germany, drugs are to a large extent provided by pharmacies. Thus, investigations in pharmacies permit drug usage studies both on patients receiving prescribable drugs and using self-medication. The current study evaluated the quality of medical care, disease burden and spectrum of treatments for patients with psoriasis in a nationwide network of pharmacies.


Patients and methods
A nationwide cross-sectional study was conducted in 61 pharmacies. Patients with psoriasis vulgaris who came to the pharmacy to obtain antipsoriatic drugs or basic ointments were consecutively recruited, interviewed and asked to complete a standardized questionnaire. The questionnaire focused on socio-demographic characteristics and prior therapies for psoriasis. Furthermore, data on the patient's treatment satisfaction, disease-related burden, and treatment adherence were evaluated. In addition, the proportion and significance of health care providers for psoriasis as well as the number of patients using self-medication were assessed.


Results
The data on 241 patients show a high and long-lasting disease-related burden. A high utilization of resources was found. Dermatologists were the most frequently consulted providers (reported by 77.1 % of patients), followed by general practitioners (10.4 %). 3.5 % of patients were using self-medication. Self-reported adherence with treatment was moderate (71.6 %). Patient satisfaction varied considerably and demonstrated the need for improvement.


Conclusions
Psoriasis is a socio-economically relevant disease. Health care is provided primarily by dermatologists. Surveying patients in a national network of pharmacies is a unique and effective way of collecting relevant “real world” data. Selection biases related to the health care setting are minimized.

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fj.1610-0387.2012.08049.x" xmlns="http://purl.org/rss/1.0/"><title>Allergies in Germany – prevalence and perception by the public</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fj.1610-0387.2012.08049.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Allergies in Germany – prevalence and perception by the public</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Matthias Augustin, Nadine Franzke, Florian C. Beikert, Rudolf Stadler, Michael Reusch, Jochen Schmitt, Ines Schäfer</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-06T06:55:03.569525-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1610-0387.2012.08049.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1610-0387.2012.08049.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fj.1610-0387.2012.08049.x</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Original Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Summary</h3>
<div class="section" id="ddg8049-sec-0010" xmlns="http://www.w3.org/1999/xhtml"><h4>Background</h4><div class="para"><p>During the recent decades allergies have become more frequent all over the world. However, it is unclear how important the topic of allergies is for the general German population and how appropriately patients with allergies are treated.</p></div></div>
<div class="section" id="ddg8049-sec-0020" xmlns="http://www.w3.org/1999/xhtml"><h4>Patients and methods</h4><div class="para"><p>A telephone survey was performed on a representative random sample of n = 1,004 adults in Germany. The survey was performed by the Forsa Institute for Social Research and Statistical Analysis, Berlin, Germany, in the period from 31 January to 2 February 2012.</p></div></div>
<div class="section" id="ddg8049-sec-0030" xmlns="http://www.w3.org/1999/xhtml"><h4>Results</h4><div class="para"><p>Of the interviewees 52 % responded that the topic of allergies concerned them; in 33 % actually an allergy had been diagnosed by a physician. The proportion of allergies in the population correlated with the level of school education and was higher among people with a higher educational status. No differences in allergy rates were found between Eastern and Western Germany. Among allergic persons, 53 % reported to be burdened by their allergy, 48 % suffered from impaired performance because of their allergic symptoms. Among people suffering from pollen allergy, only 28 % received sublingual immune therapy, with which 70 % were satisfied. While 58 % practiced self-medication, only 21 % of the allergic persons were treated with anti-allergic drugs during their allergy flares.</p></div></div>
<div class="section" id="ddg8049-sec-0040" xmlns="http://www.w3.org/1999/xhtml"><h4>Conclusions</h4><div class="para"><p>Allergic diseases are a common, often burdensome problem in the German population, but nevertheless the medical treatment of people affected is still insufficient. The proportion of patients receiving sublingual immune therapy as causal treatment is comparatively low. Active steps are needed to improve the utilization behavior of patients, e. g. to take advice of an allergy specialist.</p></div></div>
]]></content:encoded><description>


Background
During the recent decades allergies have become more frequent all over the world. However, it is unclear how important the topic of allergies is for the general German population and how appropriately patients with allergies are treated.


Patients and methods
A telephone survey was performed on a representative random sample of n = 1,004 adults in Germany. The survey was performed by the Forsa Institute for Social Research and Statistical Analysis, Berlin, Germany, in the period from 31 January to 2 February 2012.


Results
Of the interviewees 52 % responded that the topic of allergies concerned them; in 33 % actually an allergy had been diagnosed by a physician. The proportion of allergies in the population correlated with the level of school education and was higher among people with a higher educational status. No differences in allergy rates were found between Eastern and Western Germany. Among allergic persons, 53 % reported to be burdened by their allergy, 48 % suffered from impaired performance because of their allergic symptoms. Among people suffering from pollen allergy, only 28 % received sublingual immune therapy, with which 70 % were satisfied. While 58 % practiced self-medication, only 21 % of the allergic persons were treated with anti-allergic drugs during their allergy flares.


Conclusions
Allergic diseases are a common, often burdensome problem in the German population, but nevertheless the medical treatment of people affected is still insufficient. The proportion of patients receiving sublingual immune therapy as causal treatment is comparatively low. Active steps are needed to improve the utilization behavior of patients, e. g. to take advice of an allergy specialist.

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12072" xmlns="http://purl.org/rss/1.0/"><title>Early detection of cutaneous melanoma by sequential digital dermatoscopy (SDD)</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12072</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Early detection of cutaneous melanoma by sequential digital dermatoscopy (SDD)</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Sophie Luise Kraus, Holger Andreas Haenssle</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-04T04:23:16.381192-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/ddg.12072</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/ddg.12072</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12072</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Minireview</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Summary</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>The early diagnosis and excision of cutaneous melanoma is essential for an improved prognosis of the disease. Besides the investigation of pigmented lesions with the unaided eye and conventional dermatoscopy, long-term sequential digital dermatoscopy has been shown to improve the sensitivity of melanoma detection, especially in high-risk patients. In addition to the static clinical and dermatoscopic assessment, the sequential digital dermatoscopy strategy helps to detect changes over time. This review summarizes the latest developments in the field of sequential digital dermatoscopy, describes current strategies for the selection of patients and lesions to monitor, and suggests objective criteria that should lead to an excisional biopsy.</p></div>]]></content:encoded><description>

The early diagnosis and excision of cutaneous melanoma is essential for an improved prognosis of the disease. Besides the investigation of pigmented lesions with the unaided eye and conventional dermatoscopy, long-term sequential digital dermatoscopy has been shown to improve the sensitivity of melanoma detection, especially in high-risk patients. In addition to the static clinical and dermatoscopic assessment, the sequential digital dermatoscopy strategy helps to detect changes over time. This review summarizes the latest developments in the field of sequential digital dermatoscopy, describes current strategies for the selection of patients and lesions to monitor, and suggests objective criteria that should lead to an excisional biopsy.</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12037" xmlns="http://purl.org/rss/1.0/"><title>Scalp necrosis in temporal arteritis: abrupt termination of the superfi cial temporal artery as a possible precursor</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12037</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Scalp necrosis in temporal arteritis: abrupt termination of the superfi cial temporal artery as a possible precursor</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Benjamin W.C. Sim, Tanya Karaconji, Gaurav Bhardwaj, Rahul Dubey, John P. Harris, Ian C. Francis</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-01-17T11:00:09.012618-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/ddg.12037</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/ddg.12037</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12037</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Letter</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12028" xmlns="http://purl.org/rss/1.0/"><title>Unilateral finger tip ulcerations</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12028</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Unilateral finger tip ulcerations</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Francesco Savoia, Vera Tengattini, Lorenzo Valenti, Giuseppe Gaddoni, Annalisa Patrizi</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-01-07T07:05:13.427948-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/ddg.12028</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/ddg.12028</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12028</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Case for Diagnosis</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12009" xmlns="http://purl.org/rss/1.0/"><title>Brachioradial pruritus – descriptive analysis of Brazilian case series</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12009</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Brachioradial pruritus – descriptive analysis of Brazilian case series</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Paula Y. Masuda, Antonio Carlos Ceribelli Martelli, Patrick A. Wachholz, Hélcio T. Akumatsu, Ana L. G. P. Martins, Nathália M. Silva</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-01-02T05:59:17.378675-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/ddg.12009</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/ddg.12009</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12009</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Original Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Summary</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Background:</b> The epidemiology and clinical features of brachioradial pruritus are variably described in the literature. We sought to analyze these features in a large group of Brazilian patients.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Patients and Methods:</b> In a descriptive, observational study, we identified all patients with a final diagnosis of brachioradial pruritus seen over a one-year period and re-trospectively reviewed their records. The diagnosis was made after clinical-laboratory investigation had ruled out other causes of chronic pruritus. Demographic and clinical variables were collected along with pruritus characteristics, and analyzed using des-criptive statistics.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results:</b> Forty-three patients were identified; their mean age was 55.9 years, with predominance of women (81.4 %) and Caucasians (86 %). In 52 %, the pruritus worsened with heat and sun exposure; 58.1 % had intermittent complaints; the ice-pack sign was present only in 20.9 %. The arms involving dermatomes C5-C6-C7-C8 (62.8 %) were the most affected sites, while psychoactive drugs were the most frequently prescribed therapy.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Conclusions:</b> Although uncommon, brachioradial pruritus should not be neglected in dermatological diagnosis. This case series analysis indicated that Brazilian patients from a tropical climate show characteristics similar to those described in other series from more temperate regions.</p></div>
]]></content:encoded><description>

Background: The epidemiology and clinical features of brachioradial pruritus are variably described in the literature. We sought to analyze these features in a large group of Brazilian patients.
Patients and Methods: In a descriptive, observational study, we identified all patients with a final diagnosis of brachioradial pruritus seen over a one-year period and re-trospectively reviewed their records. The diagnosis was made after clinical-laboratory investigation had ruled out other causes of chronic pruritus. Demographic and clinical variables were collected along with pruritus characteristics, and analyzed using des-criptive statistics.
Results: Forty-three patients were identified; their mean age was 55.9 years, with predominance of women (81.4 %) and Caucasians (86 %). In 52 %, the pruritus worsened with heat and sun exposure; 58.1 % had intermittent complaints; the ice-pack sign was present only in 20.9 %. The arms involving dermatomes C5-C6-C7-C8 (62.8 %) were the most affected sites, while psychoactive drugs were the most frequently prescribed therapy.
Conclusions: Although uncommon, brachioradial pruritus should not be neglected in dermatological diagnosis. This case series analysis indicated that Brazilian patients from a tropical climate show characteristics similar to those described in other series from more temperate regions.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fj.1610-0387.2012.08078.x" xmlns="http://purl.org/rss/1.0/"><title>Triple swabbing allows sensitive MRSA detection in dermatologic patients of a university tertiary care hospital</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fj.1610-0387.2012.08078.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Triple swabbing allows sensitive MRSA detection in dermatologic patients of a university tertiary care hospital</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Georg Daeschlein, Tina Bloom, Sebastian von Podewils, Ojan Assadian, Johann HT Wagenvoort, Helene Riebe, Sebastian Fochler, Abdulkareem Al-Jebori, Syrus Karsai, Ellen Kaisermayer, Hermann Haase, Sebastian Scholz, Michael Jünger</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-12-04T05:45:45.8032-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1610-0387.2012.08078.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1610-0387.2012.08078.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fj.1610-0387.2012.08078.x</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Original Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Summary</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Background:</b> To optimize preventive measures to control MRSA, we investigated retrospectively the suitability of a multiple site screening model and the optimal sampling technique to detect MRSA in a university-based phlebology and skin cancer center in Germany.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Patients and Methods:</b> During 4.5 years samples of 3 712 inpatients in a dermatologic department were analyzed for MRSA by conventional microbiologic cultures and in parallel by PCR. Samples were taken from nares, wounds and skin lesions.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results:</b> MRSA was detected in 60 inpatients (1.6%). 268 of 7 269 (3.7%) samples at admission and during hospital stay were found positive – 96 (35.8%) of these were swabs of nares, 59 (22.0%) surveillance swabs, 53 (19.8%) wound swabs and 42 (15.7%)  from other dermatologic lesions. Twenty-five of 60 patients (41.7%) were found positive only in the nares, 10 (16.7%) patients only in wounds and 4 (6.7%) patients only in lesions. 166 (61.9%) of all positive culture samples became positive 24 hours after cultivation, 86 (32.1%) after 48 hours, and 16 (6.0%) after 72 hours.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Conclusions:</b> Highest sensitivity to detect MRSA can be reached by combining three swabs: nares, wounds and skin lesions (“triple-test”). Culture of screening specimens for 72 hours is recommended.</p></div>
]]></content:encoded><description>

Background: To optimize preventive measures to control MRSA, we investigated retrospectively the suitability of a multiple site screening model and the optimal sampling technique to detect MRSA in a university-based phlebology and skin cancer center in Germany.
Patients and Methods: During 4.5 years samples of 3 712 inpatients in a dermatologic department were analyzed for MRSA by conventional microbiologic cultures and in parallel by PCR. Samples were taken from nares, wounds and skin lesions.
Results: MRSA was detected in 60 inpatients (1.6%). 268 of 7 269 (3.7%) samples at admission and during hospital stay were found positive – 96 (35.8%) of these were swabs of nares, 59 (22.0%) surveillance swabs, 53 (19.8%) wound swabs and 42 (15.7%)  from other dermatologic lesions. Twenty-five of 60 patients (41.7%) were found positive only in the nares, 10 (16.7%) patients only in wounds and 4 (6.7%) patients only in lesions. 166 (61.9%) of all positive culture samples became positive 24 hours after cultivation, 86 (32.1%) after 48 hours, and 16 (6.0%) after 72 hours.
Conclusions: Highest sensitivity to detect MRSA can be reached by combining three swabs: nares, wounds and skin lesions (“triple-test”). Culture of screening specimens for 72 hours is recommended.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fj.1610-0387.2012.12506.x" xmlns="http://purl.org/rss/1.0/"><title>Therapy of severe atopic dermatitis in adults</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fj.1610-0387.2012.12506.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Therapy of severe atopic dermatitis in adults</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Mette S. Deleuran, Christian Vestergaard</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-03-14T07:03:54.575537-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1610-0387.2012.12506.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1610-0387.2012.12506.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fj.1610-0387.2012.12506.x</prism:url><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Summary</h3><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Severe atopic dermatitis has a profound effect on many aspects of the patient's life, and a combination of topical and systemic treatment is often necessary to control the disease. Systemic corticosteroids are rapidly effective, but should only be used short term for severe exacerbations because of their many long term side effects. In chronic cases, starting another systemic immunosuppressant therapy while tapering off corticosteroids should be considered. The usefulness of cyclosporin A, azathioprine, and methotrexate has been documented in clinical trials. Cyclosporin A is rapidly effective, but has a narrow therapeutic index and possible renal toxicity. Azathioprine and methotrexate have a slower onset of action and are good treatment options for many patients, but are not always tolerated. Mycophenolate mofetil, mycophenolate sodium and biologicals are other alternatives, but need to be assessed in larger randomized trials. Despite the available therapeutic repertoire, there remain patients with very severe disease in whom we are unable to obtain satisfactory control. The therapy for patients with severe psoriasis has been revolutionized during the last decade, due to the development of targeted biological therapy, and it is indeed the hope that a similar process is about to emerge also for patients suffering from severe atopic dermatitis.</p></div>]]></content:encoded><description>Severe atopic dermatitis has a profound effect on many aspects of the patient's life, and a combination of topical and systemic treatment is often necessary to control the disease. Systemic corticosteroids are rapidly effective, but should only be used short term for severe exacerbations because of their many long term side effects. In chronic cases, starting another systemic immunosuppressant therapy while tapering off corticosteroids should be considered. The usefulness of cyclosporin A, azathioprine, and methotrexate has been documented in clinical trials. Cyclosporin A is rapidly effective, but has a narrow therapeutic index and possible renal toxicity. Azathioprine and methotrexate have a slower onset of action and are good treatment options for many patients, but are not always tolerated. Mycophenolate mofetil, mycophenolate sodium and biologicals are other alternatives, but need to be assessed in larger randomized trials. Despite the available therapeutic repertoire, there remain patients with very severe disease in whom we are unable to obtain satisfactory control. The therapy for patients with severe psoriasis has been revolutionized during the last decade, due to the development of targeted biological therapy, and it is indeed the hope that a similar process is about to emerge also for patients suffering from severe atopic dermatitis.</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fj.1610-0387.2011.07880.x" xmlns="http://purl.org/rss/1.0/"><title>Eruptive multiple Spitz nevi in a patient with epilepsy and drug addiction</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fj.1610-0387.2011.07880.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Eruptive multiple Spitz nevi in a patient with epilepsy and drug addiction</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Spyridon Gkalpakiotis, Petr Arenberger, Monika Arenbergerova</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2011-12-29T16:23:36.392756-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1610-0387.2011.07880.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1610-0387.2011.07880.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fj.1610-0387.2011.07880.x</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Letter</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fj.1610-0387.2011.07813.x" xmlns="http://purl.org/rss/1.0/"><title>Virtual dermatohistopathology at http://www.pathowiki.org</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fj.1610-0387.2011.07813.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Virtual dermatohistopathology at http://www.pathowiki.org</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Mathias Roßner, Florian Roßner, Ralf Zwönitzer, Harald Hofmann, Wolfram Sterry, Thomas Kalinski</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2011-10-06T05:25:18.812901-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1610-0387.2011.07813.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1610-0387.2011.07813.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fj.1610-0387.2011.07813.x</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Review Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">no</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Summary</h3><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>PATHOWIKI (<!--TODO: clickthrough URL--><a href="http://www.pathowiki.org" title="Link to external resource: http://www.pathowiki.org">http://www.pathowiki.org</a>) is a new specialized information system in the form of a web-based wiki with content from all sub-disciplines of human pathology. Essential components are articles and specimens which are located thematically in dermatopathology. The project is presented on the basis of impressive examples and possibilities. The ability to link all kinds of content and integrate pattern analysis theories creates an effective tool for teaching and training in dermatopathology. Collaborative work ensures the effective usage of available resources and a continually growing amount of content, the quality of which depends on the number of users and should be as high as possible. Therefore, all interested colleagues are invited to support the project.</p></div>]]></content:encoded><description>PATHOWIKI (http://www.pathowiki.org) is a new specialized information system in the form of a web-based wiki with content from all sub-disciplines of human pathology. Essential components are articles and specimens which are located thematically in dermatopathology. The project is presented on the basis of impressive examples and possibilities. The ability to link all kinds of content and integrate pattern analysis theories creates an effective tool for teaching and training in dermatopathology. Collaborative work ensures the effective usage of available resources and a continually growing amount of content, the quality of which depends on the number of users and should be as high as possible. Therefore, all interested colleagues are invited to support the project.</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fj.1610-0379.2012.8018_1.x" xmlns="http://purl.org/rss/1.0/"><title>Editorial: Update onkologische Leitlinien in der Dematologie</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fj.1610-0379.2012.8018_1.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Editorial: Update onkologische Leitlinien in der Dematologie</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">A. Nast, S. Grabbe</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-07T23:25:37.691101-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1610-0379.2012.8018_1.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1610-0379.2012.8018_1.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fj.1610-0379.2012.8018_1.x</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Editorial</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">1</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">1</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fj.1610-0379.2012.8018.x" xmlns="http://purl.org/rss/1.0/"><title>Update onkologische Leitlinien in der Dematologie</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fj.1610-0379.2012.8018.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Update onkologische Leitlinien in der Dematologie</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-11T22:49:14.498307-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1610-0379.2012.8018.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1610-0379.2012.8018.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fj.1610-0379.2012.8018.x</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Dermatoonkologische Leitlinien/Dermatooncology Guidelines. German Society of Dermatology and Wiley have published this supplement without financial support</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">1</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">45</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12015_1" xmlns="http://purl.org/rss/1.0/"><title>Editorial: Update Guidelines Dermatologic Oncology</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12015_1</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Editorial: Update Guidelines Dermatologic Oncology</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">A. Nast, S. Grabbe</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-07T23:25:37.691101-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/ddg.12015_1</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/ddg.12015_1</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12015_1</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Editorial</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">1</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">1</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12015" xmlns="http://purl.org/rss/1.0/"><title>Update Guidelines Dermatologic Oncology</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12015</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Update Guidelines Dermatologic Oncology</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-29T04:57:43.741991-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/ddg.12015</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/ddg.12015</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12015</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Dermatoonkologische Leitlinien/Dermatooncology Guidelines. German Society of Dermatology and Wiley have published this supplement without financial support</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">1</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">45</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fj.1610-0379.2012.8018_2.x" xmlns="http://purl.org/rss/1.0/"><title>S1 Kurzleitlinie – Angiosarkom der Haut und Kaposi-Sarkom</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fj.1610-0379.2012.8018_2.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">S1 Kurzleitlinie – Angiosarkom der Haut und Kaposi-Sarkom</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Thomas Vogt, Norbert Brockmeyer, Heinz Kutzner, Helmut Schöfer</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-07T23:25:37.691101-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1610-0379.2012.8018_2.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1610-0379.2012.8018_2.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fj.1610-0379.2012.8018_2.x</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Angiosarkom/Kaposi-Sarkom</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12015_2" xmlns="http://purl.org/rss/1.0/"><title>Brief S1 guidelines – Cutaneous angiosarcoma and Kaposi sarcoma</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12015_2</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Brief S1 guidelines – Cutaneous angiosarcoma and Kaposi sarcoma</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Thomas Vogt, Norbert Brockmeyer, Heinz Kutzner, Helmut Schöfer</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-07T23:25:37.691101-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/ddg.12015_2</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/ddg.12015_2</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12015_2</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Dermatoonkologische Leitlinien/Dermatooncology Guidelines. German Society of Dermatology and Wiley have published this supplement without financial support</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">9</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fj.1610-0379.2012.8018_3.x" xmlns="http://purl.org/rss/1.0/"><title>S2k Kurzleitlinie – Basalzellkarzinom der Haut</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fj.1610-0379.2012.8018_3.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">S2k Kurzleitlinie – Basalzellkarzinom der Haut</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Axel Hauschild, Helmut Breuninger, Roland Kaufmann, Rolf-Dieter Kortmann, Martin Klein, Jochen Werner, Julia Reifenberger, Thomas Dirschka, Claus Garbe</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-07T23:25:37.691101-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1610-0379.2012.8018_3.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1610-0379.2012.8018_3.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fj.1610-0379.2012.8018_3.x</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Basalzellkarzinom</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">11</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">16</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12015_3" xmlns="http://purl.org/rss/1.0/"><title>Brief S2k guidelines – Basal cell carcinoma of the skin</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12015_3</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Brief S2k guidelines – Basal cell carcinoma of the skin</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Axel Hauschild, Helmut Breuninger, Roland Kaufmann, Rolf-Dieter Kortmann, Martin Klein, Jochen Werner, Julia Reifenberger, Thomas Dirschka, Claus Garbe</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-07T23:25:37.691101-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/ddg.12015_3</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/ddg.12015_3</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12015_3</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Basal cell carcinoma</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">15</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fj.1610-0379.2012.8018_4.x" xmlns="http://purl.org/rss/1.0/"><title>S2k Kurzleitlinie – Dermatofibrosarcoma protuberans</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fj.1610-0379.2012.8018_4.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">S2k Kurzleitlinie – Dermatofibrosarcoma protuberans</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Selma Ugurel, Rolf-Dieter Kortmann, Peter Mohr, Thomas Mentzel, Claus Garbe, Helmut Breuninger</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-07T23:25:37.691101-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1610-0379.2012.8018_4.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1610-0379.2012.8018_4.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fj.1610-0379.2012.8018_4.x</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Dermatofibrosarcoma protuberans</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">17</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">19</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12015_4" xmlns="http://purl.org/rss/1.0/"><title>Brief S2k guidelines – Dermatofibrosarcoma protuberans</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12015_4</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Brief S2k guidelines – Dermatofibrosarcoma protuberans</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Selma Ugurel, Rolf-Dieter Kortmann, Peter Mohr, Thomas Mentzel, Claus Garbe, Helmut Breuninger</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-07T23:25:37.691101-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/ddg.12015_4</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/ddg.12015_4</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12015_4</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Dermatofibrosarcoma protuberans</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">16</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">18</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fj.1610-0379.2012.8018_5.x" xmlns="http://purl.org/rss/1.0/"><title>S2k Kurzleitlinie – Kutane Lymphome</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fj.1610-0379.2012.8018_5.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">S2k Kurzleitlinie – Kutane Lymphome</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Rudolf Stadler, Chalid Assaf, Claus-Detlev Klemke, Dorothee Nashan, Michael Weichenthal, Reinhard Dummer, Wolfram Sterry</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-07T23:25:37.691101-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1610-0379.2012.8018_5.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1610-0379.2012.8018_5.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fj.1610-0379.2012.8018_5.x</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Kutane Lymphome</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">20</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">30</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12015_5" xmlns="http://purl.org/rss/1.0/"><title>Brief S2k guidelines – Cutaneous lymphomas</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12015_5</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Brief S2k guidelines – Cutaneous lymphomas</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Rudolf Stadler, Chalid Assaf, Claus-Detlev Klemke, Dorothee Nashan, Michael Weichenthal, Reinhard Dummer, Wolfram Sterry</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-07T23:25:37.691101-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/ddg.12015_5</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/ddg.12015_5</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12015_5</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Cutaneous lymphomas</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">19</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">28</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fj.1610-0379.2012.8018_6.x" xmlns="http://purl.org/rss/1.0/"><title>S2k Kurzleitlinie – Merkelzellkarzinom</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fj.1610-0379.2012.8018_6.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">S2k Kurzleitlinie – Merkelzellkarzinom</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Jürgen C. Becker, Chalid Assaf, Dirk Vordermark, Sven N. Reske, Jörg Hense, Therese Dettenborn, Oliver Seitz, Stephan Grabbe</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-07T23:25:37.691101-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1610-0379.2012.8018_6.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1610-0379.2012.8018_6.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fj.1610-0379.2012.8018_6.x</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Merkelzellkarzinom</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">31</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">38</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12015_6" xmlns="http://purl.org/rss/1.0/"><title>Brief S2k guidelines – Merkel cell carcinoma</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12015_6</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Brief S2k guidelines – Merkel cell carcinoma</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Jürgen C. Becker, Chalid Assaf, Dirk Vordermark, Sven N. Reske, Jörg Hense, Therese Dettenborn, Oliver Seitz, Stephan Grabbe</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-07T23:25:37.691101-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/ddg.12015_6</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/ddg.12015_6</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12015_6</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Merkel cell carcinoma</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">29</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">36</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fj.1610-0379.2012.8018_7.x" xmlns="http://purl.org/rss/1.0/"><title>S2k Kurzleitlinie – Plattenepithelkarzinom der Haut</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fj.1610-0379.2012.8018_7.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">S2k Kurzleitlinie – Plattenepithelkarzinom der Haut</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Helmut Breuninger, Thomas Eigentler, Friedrich Bootz, Axel Hauschild, Rolf-Dieter Kortmann, Klaus Wolff, Eggert Stockfleth, Rolf-Markus Szeimies, Rainer Rompel, Claus Garbe, Stephan Grabbe</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-07T23:25:37.691101-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1610-0379.2012.8018_7.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1610-0379.2012.8018_7.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fj.1610-0379.2012.8018_7.x</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Plattenepithelkarzinom</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">39</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">47</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12015_7" xmlns="http://purl.org/rss/1.0/"><title>Brief S2k guidelines – Cutaneous squamous cell carcinoma</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12015_7</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Brief S2k guidelines – Cutaneous squamous cell carcinoma</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Helmut Breuninger, Thomas Eigentler, Friedrich Bootz, Axel Hauschild, Rolf-Dieter Kortmann, Klaus Wolff, Eggert Stockfleth, Rolf-Markus Szeimies, Rainer Rompel, Claus Garbe, Stephan Grabbe</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-07T23:25:37.691101-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/ddg.12015_7</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/ddg.12015_7</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fddg.12015_7</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Cutaneous squamous cell carcinoma</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">37</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">45</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item></rdf:RDF>